Inhalimed

About

Q&A

What is Inhalimed's primary focus?

Inhalimed is developing a drug inhaler device that utilizes ultrasonic nebulizer spray technology for the inhalation delivery of pharmaceutical and wellness products.

When was Inhalimed founded?

Inhalimed was founded in 2024.

Where is Inhalimed headquartered?

Inhalimed is headquartered in Tel Aviv-Yafo, Israel.

What is the core technology behind Inhalimed's device?

The core technology behind Inhalimed's device is an ultrasonic nebulizer for drug delivery.

What are the key components of Inhalimed's inhaler device?

The device consists of two main components: a fixed electronic inhaler base with the electronic circuit and a replaceable inhaler head containing the medicine and a small ultrasonic membrane.

What is Inhalimed's primary sector?

Inhalimed's primary sector is Health Tech & Life Sciences.

What is the goal of Inhalimed's device regarding dose delivery?

Inhalimed aims to provide precise and consistent dose delivery for various formulations, adaptable to different particle sizes and viscosities.

Sectors & technology